Andrew Armstrong
@aarmstrongduke
Professor of Medicine, Surgery, Pharmacology and Cancer Biology, Duke Cancer Institute, Durham NC
ID: 791316394382090240
26-10-2016 16:31:45
848 Tweet
2,2K Followers
168 Following
Choosing an ARPI in the mHSPC setting is a highly individualized decision. Our recent MAIC analysis compares ARCHES and ARANOTE similar cohorts for efficacy of enza vs daro for improving rPFS. Interesting results! tandfonline.com/doi/full/10.10… DCI Center for Prostate & Urologic Cancers Arun Azad Duke Cancer